Provided by Tiger Trade Technology Pte. Ltd.

Neogen Corp

12.15
-0.0900-0.74%
Post-market: 12.320.1700+1.40%19:30 EDT
Volume:2.88M
Turnover:35.32M
Market Cap:2.64B
PE:-335.36
High:12.50
Open:12.40
Low:12.13
Close:12.24
52wk High:14.26
52wk Low:5.37
Shares:217.30M
Float Shares:215.78M
Volume Ratio:0.38
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0362
EPS(LYR):-0.0400
ROE:-0.38%
ROA:-0.40%
PB:1.26
PE(LYR):-303.75

Loading ...

Neogen CEO Nassif Mikheal Reports Acquisition of 370 Common Shares Worth $4,369.70

Reuters
·
Aug 06

Neogen Price Target Raised to $13.00/Share from $11.00 by Piper Sandler

Dow Jones
·
Aug 04

Why Neogen (NEOG) Is Up 28.1% After Issuing 2027 Guidance And Narrowing Annual Losses

Simply Wall St.
·
Aug 02

Neogen’s Evolving Business Model Keeps Internal Controls a Key Financial Risk

TIPRANKS
·
Aug 01

Neogen Posts Transcript of Fiscal Q4 2026 Earnings Call

Reuters
·
Aug 01

UK's Intertek H1 Revenue Rises on Divisional Growth

Reuters
·
Jul 31

Neogen Corp Reports Results for the Quarter Ended May 31 - Earnings Summary

Reuters
·
Jul 31

Neogen Fiscal Q4 Adjusted Earnings Rise, Revenue Declines

MT Newswires Live
·
Jul 30

Neogen Q4 Revenue Beats on Food Safety Segment Growth

Reuters
·
Jul 30

Neogen Q4 FY26 Net Loss Narrows to $11.3 Million; Revenue Slips 0.1% to $225.3 Million

Reuters
·
Jul 30

GUIDANCE: (NEOG) Neogen Expects Fiscal 2027 Revenue Range $880M - $885M, vs. FactSet Est of $849.1

MT Newswires Live
·
Jul 30

Neogen Q4 Adj. EPS $0.09 Beats $(0.07) Estimate, Sales $225.300M Beat $212.355M Estimate

Benzinga Earnings
·
Jul 30

Neogen Q4 EPS USD -0.05

Reuters
·
Jul 30

Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

THOMSON REUTERS
·
Jul 30

Neogen Outlook FY Adjusted Ebitda USD 180-182 Million VS. Ibes Estimate USD 179.9 Million

THOMSON REUTERS
·
Jul 30

Neogen Q4 Adjusted EPS USD 0.09 VS. Ibes Estimate USD -0.07

THOMSON REUTERS
·
Jul 30

William Blair Gives a Hold Rating to Neogen (NEOG)

TIPRANKS
·
Jul 28

Earning Preview: Neogen Corp Q4 revenue is expected to decrease by 4.31%, and institutional views are cautious

Earnings Agent
·
Jul 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG) and Cardinal Health (CAH)

TIPRANKS
·
Jul 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Jul 22